SBIR/STTR Research Award

GLUCOSE MICROMONITOR WITH RADIO INTERFACE

Award identifier 44b63f4328a3735ef1813492bf99d9b5127aebaeb7ebd1d116ef3b6b5ea6774bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MINFORMED, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Description (provided by applicant): The proposed research is aimed at developing a fully-integrated non-invasive ambulatory blood glucose monitor with interference abatement using optical absorption through the skin aimed at diabetic applications (health relatedness). The goal is to overcome current problems such as "baseline drift" and self-calibration by measuring optical absorption of every blood analyte comparable to glucose (about 28). Innovative methods will be used to decompose the measured spectrum enabling interferences with glucose measurement to be corrected, especially effects of the skin. An innovative self-calibration method is included. The specific aims are feasibility of: 1) data collection methods aimed at measuring blood glucose through the skin, 2) the least squares data analysis methods, 3) micromonitor integration (miniaturization of data collection hardware), 4) pocket monitor (data analysis hardware), software, and other peripheral needs. User interface requirements will be evaluated including PDA requirements, ability to download to a PC for further calculations, archival, trending, and needs of medical personnel. The primary thrust will be Aims 1) and 2) establishing the feasibility of the techniques for sensing and analysis. Aims 3) and 4) are paper feasibility assessments needed for Phase II. PROPOSED COMMERCIAL APPLICATION: It is well known that the commercial application of such research is enormous. Two percent of the world's population is thought to be diabetic. Perhaps 114 million indivie=duals worldwide, 16 million in the United States require regular monitoring. The market size is measured in the billions of dollars. In addition, other emerging markets, such as the artificial pancreas, will further multiply demand for our glucose monitoring technology.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.